Cargando…
Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID-19. The use of messenger RNA (mR...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040488/ https://www.ncbi.nlm.nih.gov/pubmed/33830862 http://dx.doi.org/10.1080/21645515.2021.1900713 |
_version_ | 1783677797198200832 |
---|---|
author | Hajissa, Khalid Mussa, Ali |
author_facet | Hajissa, Khalid Mussa, Ali |
author_sort | Hajissa, Khalid |
collection | PubMed |
description | The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID-19. The use of messenger RNA (mRNA) vaccine platform offers new opportunities for the development of effective vaccines. The first use of COVID-19 mRNA vaccines for individuals outside the clinical trials raised concerns over their safety and future efficacy. In social media, particularly in developing countries, widely shared false claims allege that the current mRNA-based COVID-19 vaccines potentially integrate into the host genome and thus may genetically modify humans. These vaccines are also assumed to lack efficacy due to the emergence of new strains. Such misinformation cause people to hesitate about receiving vaccination against COVID-19. This commentary aimed to outline the structure, mechanism of action and the major motive for the use of COVID-19 mRNA vaccine, with a focus on scientifically addressing challenges associated with conspiracy theories and dispelling misinformation around vaccination. |
format | Online Article Text |
id | pubmed-8040488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-80404882021-04-13 Positive aspects of the mRNA platform for SARS-CoV-2 vaccines Hajissa, Khalid Mussa, Ali Hum Vaccin Immunother Commentary The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID-19. The use of messenger RNA (mRNA) vaccine platform offers new opportunities for the development of effective vaccines. The first use of COVID-19 mRNA vaccines for individuals outside the clinical trials raised concerns over their safety and future efficacy. In social media, particularly in developing countries, widely shared false claims allege that the current mRNA-based COVID-19 vaccines potentially integrate into the host genome and thus may genetically modify humans. These vaccines are also assumed to lack efficacy due to the emergence of new strains. Such misinformation cause people to hesitate about receiving vaccination against COVID-19. This commentary aimed to outline the structure, mechanism of action and the major motive for the use of COVID-19 mRNA vaccine, with a focus on scientifically addressing challenges associated with conspiracy theories and dispelling misinformation around vaccination. Taylor & Francis 2021-04-08 /pmc/articles/PMC8040488/ /pubmed/33830862 http://dx.doi.org/10.1080/21645515.2021.1900713 Text en © 2021 Taylor & Francis Group, LLC |
spellingShingle | Commentary Hajissa, Khalid Mussa, Ali Positive aspects of the mRNA platform for SARS-CoV-2 vaccines |
title | Positive aspects of the mRNA platform for SARS-CoV-2 vaccines |
title_full | Positive aspects of the mRNA platform for SARS-CoV-2 vaccines |
title_fullStr | Positive aspects of the mRNA platform for SARS-CoV-2 vaccines |
title_full_unstemmed | Positive aspects of the mRNA platform for SARS-CoV-2 vaccines |
title_short | Positive aspects of the mRNA platform for SARS-CoV-2 vaccines |
title_sort | positive aspects of the mrna platform for sars-cov-2 vaccines |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040488/ https://www.ncbi.nlm.nih.gov/pubmed/33830862 http://dx.doi.org/10.1080/21645515.2021.1900713 |
work_keys_str_mv | AT hajissakhalid positiveaspectsofthemrnaplatformforsarscov2vaccines AT mussaali positiveaspectsofthemrnaplatformforsarscov2vaccines |